TLC BioSciences

TLC BioSciences is a clinical-stage specialty pharmaceutical company dedicated to the research and development of novel nanomedicines to maximize the potential of its proprietary lipid-assembled drug delivery platform (LipAD)®. TLC's extensive experience in liposome science allows for the combination of rapid onset and prolonged benefit duration, enhancing active drug concentration while minimizing unnecessary systemic exposure. TLC possesses a diversified portfolio of wholly-owned therapies targeting unmet medical needs in pain management, infectious diseases, ophthalmology, and oncology.